Polyoxidonium® drug and Grippol® Quadrivalent vaccine are included in the guidelines for ARVIs prevention
In October 2022, the Federal Medical and Biological Agency published updated guidelines «Influenza and other acute respiratory viral infections during the ongoing COVID-19 pandemic: prevention and treatment», and included Polyoxidonium® drug and Grippol® Quadrivalent influenza vaccine in the guidelines.
A new guide for doctors on COVID-19 vaccination in patients with comorbid diseases has been published
